SUDEEP PHARMA LIMITED (SUDEEPPHRM) financials

SUDEEP PHARMA LIMITED (SUDEEPPHRM) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.[1]

Market Cap: ₹10,868Cr.
Current Price: ₹962
Stock P/E: 93.5
ROE: 17.7%
ROCE: 20.7%
Book Value: ₹69.6
Dividend Yield: 0.16%
52W High / Low: ₹1,378/524

In Jun 2026, SUDEEP PHARMA LIMITED (SUDEEPPHRM) reported sales ₹106 Cr and net profit ₹34 Cr.

Annual TTM: sales ₹364 Cr, net profit ₹116 Cr.

Shareholding: Promoters 76.16% (Sep 2026), FIIs 2.93% (Sep 2026), DIIs 14.06% (Sep 2026), Public 6.87% (Sep 2026), No. of Shareholders 40,465% (Sep 2026).

SUDEEPPHRM quarterly results (₹ Cr.)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	83	105	80	88	90	80	106
Expenses	57	59	50	57	61	51	66
Operating Profit	26	45	30	31	30	29	39
OPM %	32%	43%	38%	35%	33%	36%	37%
Other Income	2	3	7	13	9	10	10
Interest	1	2	1	2	1	2	2
Depreciation	2	2	2	2	2	2	2
Profit before tax	26	45	34	40	37	35	45
Tax %	21%	27%	26%	25%	27%	26%	26%
Net Profit	21	33	25	30	27	26	34
EPS in Rs	2.12	3.41	2.59	3.06	2.38	2.28	3.00
Raw PDF	—	—	—	—	—	—	—

SUDEEPPHRM profit and loss (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	218	345	404	344	357	339	364
Expenses	172	277	315	211	224	218	235
Operating Profit	46	68	89	133	133	120	129
OPM %	21%	20%	22%	39%	37%	36%	35%
Other Income	4	8	11	8	8	38	42
Interest	1	2	5	4	6	7	6
Depreciation	4	4	5	5	6	7	7
Profit before tax	45	70	91	132	129	145	157
Tax %	22%	26%	26%	26%	26%	26%	—
Net Profit	35	52	67	98	96	108	116
EPS in Rs	4.17	6.23	8.00	11.68	9.85	9.52	10.72
Dividend Payout %	0%	0%	0%	0%	0%	0%	—

SUDEEPPHRM balance sheet (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	1	1	1	1	10	11
Reserves	115	167	235	333	418	775
Borrowings	31	73	71	60	123	127
Other Liabilities	67	92	109	56	54	61
Total Liabilities	214	333	416	451	604	974
Fixed Assets	68	120	90	96	105	102
CWIP	23	4	26	44	88	161
Investments	24	15	19	29	32	32
Other Assets	99	194	282	282	380	679
Total Assets	214	333	416	451	604	974

SUDEEPPHRM cash flows (₹ Cr.)
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	36	-5	42	59	59	96
Cash from Investing Activity	-45	-28	-41	-41	-92	-367
Cash from Financing Activity	13	40	-10	-16	54	242
Net Cash Flow	4	7	-9	2	22	-28
Free Cash Flow	24	-62	4	27	-2	30
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	101%	17%	72%	72%	67%	111%

SUDEEPPHRM shareholding pattern (%)
Category	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	76.16%	76.16%	76.16%	76.16%
FIIs	1.67%	1.55%	1.81%	2.93%
DIIs	17.59%	18.11%	15.64%	14.06%
Public	4.57%	4.18%	6.39%	6.87%
No. of Shareholders	43,599	36,503	35,695	40,465

SUDEEPPHRM key ratios
Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	97	130	114	150	166	86
Inventory Days	66	71	115	131	199	463
Days Payable	73	65	86	99	110	151
Cash Conversion Cycle	90	136	143	182	255	399
Working Capital Days	15	37	57	125	140	240
ROCE %	—	37%	35%	39%	29%	21%

SUDEEPPHRMUpdated 23 Oct 2026, 2:09

Sudeep Pharma Limited

SUDEEPPHRMUpdated 23 Oct 2026, 2:09

Market Cap

₹10,868Cr.

Current Price

₹962

High / Low

₹1,378/524

Stock P/E

93.5

Book Value₹69.6

Dividend Yield0.16%

ROCE20.7%

ROE17.7%

Face Value₹1.00

About

Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Dec 2024	83	1	57	2	2	26	21	21	2.12
Mar 2025	105	2	59	3	2	45	27	33	3.41
Jun 2025	80	1	50	7	2	34	26	25	2.59
Sep 2025	88	2	57	13	2	40	25	30	3.06
Dec 2025	90	1	61	9	2	37	27	27	2.38
Mar 2026	80	2	51	10	2	35	26	26	2.28
Jun 2026	106	2	66	10	2	45	26	34	3

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2021	218	1	172	4	4	45	22	35	4.17
Mar 2022	345	2	277	8	4	70	26	52	6.23
Mar 2023	404	5	315	11	5	91	26	67	8
Mar 2024	344	4	211	8	5	132	26	98	11.68
Mar 2025	357	6	224	8	6	129	26	96	9.85
Mar 2026	339	7	218	38	7	145	26	108	9.52
TTM	364	6	235	42	7	157	—	116	10.72

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	76.16%
FIIs	2.93%
DIIs	14.06%
Public	6.87%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2025	76.16%	1.67%	17.59%	4.57%
Mar 2026	76.16%	1.55%	18.11%	4.18%
Jun 2026	76.16%	1.81%	15.64%	6.39%
Sep 2026	76.16%	2.93%	14.06%	6.87%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2021	1	115	31	67	214	68	23	24	99	214
Mar 2022	1	167	73	92	333	120	4	15	194	333
Mar 2023	1	235	71	109	416	90	26	19	282	416
Mar 2024	1	333	60	56	451	96	44	29	282	451
Mar 2025	10	418	123	54	604	105	88	32	380	604
Mar 2026	11	775	127	61	974	102	161	32	679	974

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2021	36	-45	13	4
Mar 2022	-5	-28	40	7
Mar 2023	42	-41	-10	-9
Mar 2024	59	-41	-16	2
Mar 2025	59	-92	54	22
Mar 2026	96	-367	242	-28

Key ratios

Historical financial ratios

Category	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	97	130	114	150	166	86
Inventory Days	66	71	115	131	199	463
Days Payable	73	65	86	99	110	151
Cash Conversion Cycle	90	136	143	182	255	399
Working Capital Days	15	37	57	125	140	240
ROCE %	—	37%	35%	39%	29%	21%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SUDEEP PHARMA LIMITED (SUDEEPPHRM)?

The reported market capitalisation for SUDEEP PHARMA LIMITED (SUDEEPPHRM) is ₹10,868Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SUDEEPPHRM?

The current price shown for SUDEEP PHARMA LIMITED (SUDEEPPHRM) on Fincrux is ₹962 with a 52-week high/low of ₹1,378/524.

What is the P/E ratio of SUDEEP PHARMA LIMITED (SUDEEPPHRM)?

The stock P/E for SUDEEP PHARMA LIMITED (SUDEEPPHRM) is 93.5 on Fincrux, with ROE at 17.7% and ROCE at 20.7%.

What were SUDEEPPHRM latest quarterly results?

For Jun 2026, SUDEEP PHARMA LIMITED (SUDEEPPHRM) reported sales ₹106 Cr and net profit ₹34 Cr (figures in ₹ crore unless noted).

What are SUDEEPPHRM annual sales and net profit?

For TTM, SUDEEP PHARMA LIMITED (SUDEEPPHRM) shows sales of ₹364 Cr and net profit of ₹116 Cr on the Fincrux profit & loss statement.

Who owns SUDEEP PHARMA LIMITED (SUDEEPPHRM)?

Latest shareholding for SUDEEP PHARMA LIMITED (SUDEEPPHRM) on Fincrux: Promoters 76.16% (Sep 2026), FIIs 2.93% (Sep 2026), DIIs 14.06% (Sep 2026), Public 6.87% (Sep 2026), No. of Shareholders 40,465% (Sep 2026).

Where can I find SUDEEP PHARMA LIMITED (SUDEEPPHRM) financials?

SUDEEP PHARMA LIMITED (SUDEEPPHRM) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SUDEEPPHRM balance sheet and cash flow?

Yes. The SUDEEP PHARMA LIMITED (SUDEEPPHRM) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 23 October 2026 at 2:09